Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A cohort study and meta-analysis between histopathological classification and prognosis of gastric carcinoma.

Liu L, Wang ZW, Ji J, Zhang JN, Yan M, Zhang J, Liu BY, Zhu ZG, Yu YY.

Anticancer Agents Med Chem. 2013 Feb;13(2):227-34.

PMID:
22934699
2.

Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases.

Hass HG, Smith U, Jäger C, Schäffer M, Wellhäuber U, Hehr T, Markmann HU, Nehls O, Denzlinger C.

Onkologie. 2011;34(12):682-6. doi: 10.1159/000334545. Epub 2011 Nov 21.

PMID:
22156447
3.
4.

Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis.

Luebke T, Baldus SE, Grass G, Bollschweiler E, Thiele J, Dienes HP, Hoelscher AH, Moenig SP.

World J Surg. 2005 Nov;29(11):1422-7; discussion 1428.

PMID:
16222448
5.

Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis.

Mönig S, Baldus SE, Collet PH, Zirbes TK, Bollschweiler E, Thiele J, Dienes HP, Hölscher AH.

Anticancer Res. 2001 Jan-Feb;21(1B):617-20.

PMID:
11299815
7.

The decision criterion of histological mixed type in "T1/T2" gastric carcinoma--comparison between TNM classification and Japanese Classification of Gastric Cancer.

Shimizu H, Ichikawa D, Komatsu S, Okamoto K, Shiozaki A, Fujiwara H, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Kishimoto M, Yanagisawa A, Otsuji E.

J Surg Oncol. 2012 Jun 15;105(8):800-4. doi: 10.1002/jso.23010. Epub 2011 Dec 20.

PMID:
22189799
8.

Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.

Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S.

Cancer. 2000 Oct 1;89(7):1418-24.

PMID:
11013353
9.

Histotype-based prognostic classification of gastric cancer.

Chiaravalli AM, Klersy C, Vanoli A, Ferretti A, Capella C, Solcia E.

World J Gastroenterol. 2012 Mar 7;18(9):896-904. doi: 10.3748/wjg.v18.i9.896.

10.

[The clinical significance of the histological classification of stomach cancer after Laurén].

Iarv VR, Saar KhE, Villako KP.

Vopr Onkol. 1991;37(1):45-8. Russian.

PMID:
2014679
11.

Incidence and prognosis of gastric cancer in a population-based cohort survey: the Hisayama study.

Tanaka K, Kiyohara Y, Kato I, Matsumoto T, Yamagata H, Kubo M, Tanizaki Y, Okubo K, Nakamura H, Iwamoto H, Nakayama K, Iida M.

Scand J Gastroenterol. 2004 May;39(5):459-63.

PMID:
15180184
12.

Gastric cancer: correlation between clinicopathological factors and survival of patients. II.

Lazăr D, Tăban S, Sporea I, Dema A, Cornianu M, Lazăr E, Goldiş A, Vernic C.

Rom J Morphol Embryol. 2009;50(2):185-94.

13.

[Goseki classification in adenocarcinoma of the cardia].

De Manzoni G, Pedrazzani C, Di Leo A, Bonfiglio M, Zerman G, Tasselli S, Borzellino G.

Minerva Chir. 2002 Aug;57(4):449-55. Italian.

PMID:
12145574
14.

[Relationship between histologic type and location of gastric adenocarcinoma in the Rebagliati Hospital].

Quiñones J, Portanova M, Yabar A.

Rev Gastroenterol Peru. 2011 Apr-Jun;31(2):139-45. Spanish.

PMID:
21836654
15.

Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.

Lorenzen S, Blank S, Lordick F, Siewert JR, Ott K.

Ann Surg Oncol. 2012 Jul;19(7):2119-27. doi: 10.1245/s10434-012-2254-1. Epub 2012 Mar 7.

PMID:
22395980
16.

Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.

Lazăr D, Tăban S, Raica M, Sporea I, Cornianu M, Goldiş A, Vernic C.

Rom J Morphol Embryol. 2008;49(2):137-48.

17.

A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients.

Tural D, Selçukbiricik F, Serdengeçti S, Büyükünal E.

World J Surg Oncol. 2012 Nov 2;10:234. doi: 10.1186/1477-7819-10-234.

18.

Shifting proportions of gastric adenocarcinomas.

Salvon-Harman JC, Cady B, Nikulasson S, Khettry U, Stone MD, Lavin P.

Arch Surg. 1994 Apr;129(4):381-8; discussion 388-9.

PMID:
7512326
19.

Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.

Borch K, Jönsson B, Tarpila E, Franzén T, Berglund J, Kullman E, Franzén L.

Br J Surg. 2000 May;87(5):618-26.

PMID:
10792320
20.

Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas.

Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, Tseng HH, Chou NH, Huang MS, Tseng CJ, Hsiao M.

Cancer Lett. 2003 Nov 10;201(1):97-106.

PMID:
14580691

Supplemental Content

Support Center